On Monday, the Supreme Court of India dismissed a plea seeking removal of levy of Goods and Services Tax on medicines to cure spinal muscular atrophy (SMA) stating that its a 'policy decision'.The petitioner was seeking a GST exemption on medical treatment of patients suffering from SMA. He submitted that the the Drugs for SMA are prohibitively priced. One dose of Zolegsnama is Rs 17 crores....
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok